Testing honey for moderate cervical cell changes
Part of Infections, Women’s health & pregnancy clinical trials.
This study tests whether honey applied directly to the cervix can help reverse moderate cervical cell changes (CIN II). It may offer a natural alternative to more invasive procedures.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 18 and 40 years old.
- You have a first-time CIN II diagnosis (moderate abnormal cell changes in the cervix) confirmed by a biopsy.
- You can read and understand Dutch well.
- You are not pregnant and do not plan to become pregnant during the study.
- You are not allergic to honey.
- You do not have an active high-risk HPV infection (negative test), a weakened immune system, or a history of cervical cancer or previous CIN treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for ways to predict who will respond to imiquimod cream for precancerous cervical cell changes (CIN2 or CIN3). Results may help doctors choose the best treatment approach and better plan follow-up.
This trial studies 2LPAPI® to see if it helps the body clear high-risk HPV infections in the cervix. It may be an option if you have a current HPV infection with mild/early abnormal cervical findings and can complete follow-up for about a year.
This study tests a special light-based treatment (called HAL-PDT) for early cervical changes (CIN2) that were found on a recent biopsy. The goal is to see if this treatment can safely remove these changes and prevent them from becoming cancer.
This study follows women with an early abnormal cervix cell change (CIN2/CIN2-3) to see how HPV DNA “integration” relates to whether the condition improves or worsens. It may help doctors better predict prognosis and guide safer monitoring, especially if you want to become pregnant.
This Phase 2 study tests whether a curcumin (a natural plant compound) cream/gel applied to the cervix can help treat cervical cell changes linked to HPV. It focuses on people with mild (LSIL) or recently treated severe (HSIL) precancer changes, aiming to reduce disease and improve healing.
This study tests a new tool called PreCursor-M+® to see how well it helps doctors manage CIN2, a moderate cervical cell change. It’s for people who have already been diagnosed with CIN2 and know their HPV test results.
Hear when a new Cervical Intraepithelial Neoplasia-II trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.